Cochrane · systematic review · CD006102
Smoking cessation interventions for smokers with current or past depression
van der Meer, RM, Willemsen, MC, Smit, F, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Tobacco AddictionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Psychosocial mood management versus control for smokers with current depression. Abstinence at six months or longer follow‐up
Population: smokers with current depression1
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Smoking cessation Biochemical validation (minority) and self report Psychosocial mood management vs control | RR 1.47 [1.13, 1.92] | 11 studies · 1844 participants | Low Downgraded: risk of bias |
Bupropion versus control for smokers with current depression. Abstinence at six months or longer follow‐up
Population: smokers with current depression
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Bupropion versus placebo All biochemically validated Bupropion vs control | RR 1.37 [0.83, 2.27] | 5 studies · 410 participants | Low Downgraded: risk of bias |
Psychosocial mood management versus control for smokers with past depression. Abstinence at six months or longer follow‐up
Population: patients with smokers with past depression
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Smoking cessation Biochemical validation (majority) and self report Psychosocial mood management vs control | RR 1.41 [1.13, 1.77] | 13 studies · 1496 participants | Low Downgraded: risk of bias |
Bupropion versus control for smokers with past depression. Abstinence at six months or longer follow‐up
Population: patients with smokers with past depression
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Bupropion versus placebo Biochemical validation (majority) and self report Bupropion vs control | RR 2.04 [1.31, 3.18] | 4 studies · 404 participants | Low Downgraded: risk of bias |